Mr. Sam D. Colella is Independent Director at Flexion Therapeutics, Inc., Chairman at Fluidigm Corp., a Managing Director at Versant Venture Management LLC, and a Principal at ArthroCare Corp.
He is on the Board of Directors at Flexion Therapeutics, Inc., Rennovia, Inc., Kinestral Technologies, Inc., and Quanticel Pharmaceuticals, Inc.
Mr. Colella was previously employed as Independent Director by Jazz Pharmaceuticals, Inc., General Partner by Institutional Venture Partners, a Principal by Argonaut Technologies, Inc., a Principal by Athena Neurosciences, Inc., a Principal by Aviron, Inc., a Principal by CV Therapeutics, Inc., a Principal by EndoSonics Corp., a Principal by GenPharm International, Inc., a Principal by Imagyn Medical, Inc., a Principal by IVAC Holdings, Inc., a Principal by National Venture Capital Association, a Principal by Onyx Pharmaceuticals, Inc., a Principal by Pharmacopeia LLC, a Principal by Tularik, Inc., and a Principal by Western Association of Venture Capitalists.
He also served on the board at Symyx Technologies, Inc. and Thermage, Inc.
He received his undergraduate degree from the University of Pittsburgh, an MBA from the Stanford Graduate School of Business, and an MBA from Stanford University.